Glaukos Corporation GKOS
i
Market dataready · fetched 2026-11-12T00:54:13.665Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.002335529Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T00:54:13.267113+00:00
Glaukos Corporation options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 268.24 | 57.3% | 9.5% | 228.95 | 61.6% | 8.5% |
| 25Δ | 263.67 | 55.0% | 7.9% | 232.98 | 59.3% | 7.2% |
| 30Δ | 259.46 | 53.4% | 6.5% | 236.54 | 57.6% | 6.1% |
| 35Δ | 256.69 | 54.3% | 5.8% | 240.08 | 56.0% | 5.0% |
| 40Δ | 253.91 | 55.2% | 5.2% | 242.80 | 55.5% | 4.4% |
| 45Δ | 251.14 | 56.1% | 4.5% | 245.53 | 55.0% | 3.8% |
| 50Δ | 248.31 | 57.1% | 3.9% | 248.26 | 54.5% | 3.2% |
| 55Δ | 245.43 | 58.1% | 3.4% | 251.01 | 54.1% | 2.7% |
| 60Δ | 242.55 | 59.0% | 2.9% | 253.80 | 53.7% | 2.3% |
| 65Δ | 239.61 | 59.9% | 2.4% | 256.59 | 53.3% | 1.8% |
| 70Δ | 236.20 | 60.3% | 2.0% | 259.38 | 53.0% | 1.4% |
| 75Δ | 232.80 | 60.6% | 1.6% | 262.99 | 53.1% | 1.1% |
| 80Δ | 228.97 | 61.6% | 1.2% | 266.83 | 53.3% | 0.8% |
20Δ
- Pseudo strike
- 268.24
- IV
- 57.3%
- B/E move
- 9.5%
- Pseudo strike
- 228.95
- IV
- 61.6%
- B/E move
- 8.5%
25Δ
- Pseudo strike
- 263.67
- IV
- 55.0%
- B/E move
- 7.9%
- Pseudo strike
- 232.98
- IV
- 59.3%
- B/E move
- 7.2%
30Δ
- Pseudo strike
- 259.46
- IV
- 53.4%
- B/E move
- 6.5%
- Pseudo strike
- 236.54
- IV
- 57.6%
- B/E move
- 6.1%
35Δ
- Pseudo strike
- 256.69
- IV
- 54.3%
- B/E move
- 5.8%
- Pseudo strike
- 240.08
- IV
- 56.0%
- B/E move
- 5.0%
40Δ
- Pseudo strike
- 253.91
- IV
- 55.2%
- B/E move
- 5.2%
- Pseudo strike
- 242.80
- IV
- 55.5%
- B/E move
- 4.4%
45Δ
- Pseudo strike
- 251.14
- IV
- 56.1%
- B/E move
- 4.5%
- Pseudo strike
- 245.53
- IV
- 55.0%
- B/E move
- 3.8%
50Δ
- Pseudo strike
- 248.31
- IV
- 57.1%
- B/E move
- 3.9%
- Pseudo strike
- 248.26
- IV
- 54.5%
- B/E move
- 3.2%
55Δ
- Pseudo strike
- 245.43
- IV
- 58.1%
- B/E move
- 3.4%
- Pseudo strike
- 251.01
- IV
- 54.1%
- B/E move
- 2.7%
60Δ
- Pseudo strike
- 242.55
- IV
- 59.0%
- B/E move
- 2.9%
- Pseudo strike
- 253.80
- IV
- 53.7%
- B/E move
- 2.3%
65Δ
- Pseudo strike
- 239.61
- IV
- 59.9%
- B/E move
- 2.4%
- Pseudo strike
- 256.59
- IV
- 53.3%
- B/E move
- 1.8%
70Δ
- Pseudo strike
- 236.20
- IV
- 60.3%
- B/E move
- 2.0%
- Pseudo strike
- 259.38
- IV
- 53.0%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 232.80
- IV
- 60.6%
- B/E move
- 1.6%
- Pseudo strike
- 262.99
- IV
- 53.1%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 228.97
- IV
- 61.6%
- B/E move
- 1.2%
- Pseudo strike
- 266.83
- IV
- 53.3%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 43.03% | |
| 41.17% | |
| 43.24% | |
| 44.41% | |
| 44.65% | |
| 50.58% | |
| 46.45% | |
| 46.01% | |
| 46.75% | |
| 46.61% | |
| 46.86% | |
| 46.55% | |
| 45.84% | |
| 47.93% | |
| 48.20% | |
| 46.80% | |
| 47.86% | |
| 50.13% | |
| 49.54% | |
| 50.23% | |
| 49.89% | |
| 52.18% | |
| 51.60% | |
| 52.79% | |
| 56.18% | |
| 50.92% | |
| 51.15% | |
| 50.98% | |
| 51.83% | |
| 50.25% | |
| 51.97% | |
| 54.63% | |
| 54.64% | |
| 55.12% | |
| 55.72% | |
| 56.43% | |
| 58.92% | |
| 58.60% | |
| 53.47% | |
| 58.19% | |
| 56.20% | |
| 57.98% | |
| 58.70% | |
| 62.02% | |
| 62.96% | |
| 59.96% | |
| 60.14% | |
| 59.19% | |
| 59.33% | |
| 60.63% | |
| 60.19% | |
| 62.14% | |
| 61.97% | |
| 67.09% | |
| 48.55% | |
| 48.45% |
Medical Devices
GMED
Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon,…
More →HAE
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
More →HYPR
Hyperfine Inc. is a pioneering force in medical technology, renowned for developing the world’s first FDA-cleared portable MRI system, which significantly enhances diagnostic…
More →IART
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics,…
More →INFU
InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.
More →INGN
Description unavailable
More →